Search clinical trials for: Neratinib
Total 177 results
-
Puma Biotechnology, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterNo longer available
-
Pierre Fabre MedicamentNot yet recruiting
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Completed
-
Pierre Fabre Pharma GmbHiOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AGActive, not recruiting
-
Puma Biotechnology, Inc.Completed
-
Puma Biotechnology, Inc.Withdrawn
-
Convalife (Shanghai) Co., Ltd.Not yet recruiting
-
Virginia Commonwealth UniversityGlaxoSmithKline; Puma Biotechnology, Inc.RecruitingOvarian Cancer | Advanced Solid TumorUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
Jules Bordet InstituteWithdrawn
-
Puma Biotechnology, Inc.CompletedHepatic InsufficiencyRussian Federation
-
Puma Biotechnology, Inc.Completed
-
Bristol-Myers SquibbRecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisItaly
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationCompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
Puma Biotechnology, Inc.CompletedHealthy SubjectsUnited States
-
Baylor Research InstituteNot yet recruitingBreast Cancer | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Puma Biotechnology, Inc.Completed
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Completed
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, Korea, Republic of, China, United Kingdom, Canada, France, Australia, Denmark, Switzerland, Japan, Malaysia, Italy, Singapore, Taiwan, Belgium, Croatia, Czechia, Romania, Germany, Bahamas, Brazil, Bulgaria, Colombia and more
-
University Health Network, TorontoRecruitingBreast Cancer | HER2-positive Breast CancerCanada
-
Korea University Guro HospitalKorean Cancer Study GroupActive, not recruitingMetastatic Cancer | HER2 Gene MutationKorea, Republic of
-
CelgeneActive, not recruiting
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHER2-positive Breast Cancer
-
NSABP Foundation IncWithdrawnColorectal CancerUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationAvailable
-
Qilu Pharmaceutical Co., Ltd.UnknownAdvanced Breast CancerChina
-
NSABP Foundation IncPuma Biotechnology, Inc.Completed
-
SOLTI Breast Cancer Research GroupTerminated
-
Puma Biotechnology, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States, France, Hungary, Poland, Spain
-
Guangdong Association of Clinical TrialsRecruitingALK Positive Non-small Cell Lung CancerChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLCChina
-
Puma Biotechnology, Inc.CompletedNeoplasms | Breast NeoplasmsUnited States, Belgium, India, China, Russian Federation, Mexico, France
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.RecruitingNSCLC Stage IV | NSCLC Stage IIIB | ALK PositiveChina
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbRecruitingMDS | Myeloproliferative Neoplasm | Chronic Neutrophilic LeukemiaUnited States
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Puma Biotechnology, Inc.Not yet recruitingInvasive Breast Lobular Carcinoma | Anatomic Stage I Breast Cancer | Anatomic Stage II Breast Cancer | Anatomic Stage III Breast CancerUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixNovartis; Wayne State University; Translational Genomics Research InstituteCompletedGlioblastoma | Brain MetastasesUnited States
-
Puma Biotechnology, Inc.CompletedAdvanced Malignant Solid TumorsJapan
-
Puma Biotechnology, Inc.CompletedAdvanced Breast CancerUnited States, Switzerland, China, France
-
West Cancer CenterPuma Biotechnology, Inc.; Celcuity IncActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Early-stage Breast CancerUnited States
-
Anne Beaven, MDNovartisWithdrawnHematologic MalignanciesUnited States
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania